C. Taylor

发表

Current and Emerging Techniques for Diagnostic Mutation Detection

G. Taylor, C. Taylor, Claire F. Taylor, 2004 .

Genomic Subtypes of Non-invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation Frequency.

Olivia Alder, Alastair Droop, Lucy F. Stead, 2017, Cancer cell.

Novel Tumor Subgroups of Urothelial Carcinoma of the Bladder Defined by Integrated Genomic Analysis

C. Taylor, M. Knowles, C. Hurst, 2012, Clinical Cancer Research.

JARID2 facilitates transcriptional reprogramming in glioblastoma in response to standard treatment

M. Care, A. Brodbelt, C. Taylor, 2019, bioRxiv.

MRE11 expression is predictive of cause-specific survival following radical radiotherapy for muscle-invasive bladder cancer.

Ananya Choudhury, D. Bishop, R. Bristow, 2010, Cancer research.

Colorectal Tumors from APC*I1307K Carriers Principally Harbor Somatic APC Mutations outside the A8 Tract

I. Tomlinson, T. Bishop, C. Taylor, 2014, PloS one.

Mutation cluster region, association between germline and somatic mutations and genotype-phenotype correlation in upper gastrointestinal familial adenomatous polyposis.

I. Tomlinson, C. Taylor, S. Hodgson, 2002, The American journal of pathology.

No Evidence for BRAF as a Melanoma/Nevus Susceptibility Gene

D. Bishop, I. Dos Santos Silva, A. Swerdlow, 2005, Cancer Epidemiology Biomarkers & Prevention.

Molecular Profiling in Daily Clinical Practice: Practicalities in Advanced Cholangiocarcinoma and Other Biliary Tract Cancers

C. Taylor, A. Lamarca, J. Valle, 2020, Journal of clinical medicine.

Mutation analysis of the 8p candidate tumour suppressor genes DBC2 (RHOBTB2) and LZTS1 in bladder cancer.

C. Taylor, M. Knowles, P. Harnden, 2005, Cancer letters.

Sequence variation in the I-like domain of the beta1 integrin subunit in human oral squamous cell carcinomas.

F. Watt, C. Taylor, Judith Jones, 2004, Cancer letters.

Genomic Subtypes of Non-Invasive Bladder Cancer with Distinct Metabolic Profile, Clinical Outcome and Female Gender Bias in KDM6A Mutation Frequency

Lucy F. Stead, D. Gordenin, L. Klimczak, 2017 .

The role of microRNA-binding site polymorphisms in DNA repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomes

D. Bishop, D. Cox, A. Kiltie, 2011, Carcinogenesis.

A comparison of CDKN2A mutation detection within the Melanoma Genetics Consortium (GenoMEL).

S. Puig, D. Bishop, D. Elder, 2008, European journal of cancer.

CDKN2A and CDK4 variants in Latvian melanoma patients: analysis of a clinic-based population

D. Bishop, J. Lubiński, C. Taylor, 2007, Melanoma research.

High-Resolution Copy Number Patterns From Clinically Relevant FFPE Material

C. Taylor, D. Bishop, M. Harland, 2019, Scientific Reports.

Prevalence and predictors of germline CDKN2A mutations for melanoma cases from Australia

J. Malvehy, S. Puig, J. Barrett, 2014 .

Prevalence and predictors of germline CDKN2A mutations for melanoma cases from Australia, Spain and the United Kingdom

J. Malvehy, S. Puig, J. Barrett, 2014, Hereditary cancer in clinical practice.

Prevalence and predictors of germline CDKN2A mutations for melanoma cases from Australia, Spain and the United Kingdom

J. Malvehy, S. Puig, J. Barrett, 2014, Hereditary Cancer in Clinical Practice.

A NOVEL TYROSINE KINASE ACTIVITY IN THE COTTON LEAFWORM, SPODOPTERA LITTORALIS

A. F. Durkin, M. Fisher, C. Taylor, 1994 .

Fungal pathogenesis: Past, present and future

C. Taylor, S. Gurr, Claire F. Taylor, 2014 .

Heart allograft acceptance induced by anti-CD3 antibody in high-responder rats: effect on foxp3 and cytokine expression and graft infiltration.

C. Taylor, Chuanming Wang, G. Bishop, 2008, Transplant immunology.

Human Cancer Biology Novel Tumor Subgroups of Urothelial Carcinoma of the Bladder De fi ned by Integrated Genomic Analysis

C. Taylor, M. Knowles, C. Hurst, 2012 .

Examination of single and multiple mutations involved in resistance to quinolones in Staphylococcus aureus by a combination of PCR and denaturing high-performance liquid chromatography (DHPLC).

J. Ambler, C. Taylor, P. Hawkey, 2002, The Journal of antimicrobial chemotherapy.

Exploratory Study of MYD88 L265P, Rare NLRP3 Variants, and Clonal Hematopoiesis Prevalence in Patients With Schnitzler Syndrome

C. Taylor, P. Hawkins, D. Rowczenio, 2019, Arthritis & rheumatology.

The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival.

L. Staudt, A. Rosenwald, W. Chan, 2008, Blood.

Clinical and molecular phenotype of Aicardi-Goutieres syndrome.

A. Green, D. Bonthron, E. Bertini, 2007, American journal of human genetics.

Analysis of VHL Gene Alterations and their Relationship to Clinical Parameters in Sporadic Conventional Renal Cell Carcinoma

W. Gregory, C. Taylor, M. Knowles, 2009, Clinical Cancer Research.

Spectrum of Phosphatidylinositol 3-Kinase Pathway Gene Alterations in Bladder Cancer

W. Gregory, C. Taylor, M. Knowles, 2009, Clinical Cancer Research.

High-Resolution Copy Number Patterns From Clinically Relevant FFPE Material

C. Taylor, D. Bishop, M. Harland, 2019, Scientific Reports.

FGFR3 and Ras gene mutations are mutually exclusive genetic events in urothelial cell carcinoma

Adel H Jebar, C. Taylor, M. Knowles, 2005, Oncogene.

A mutation hotspot at the p14ARF splice site

J. A. Bishop, D. Bishop, M. Tucker, 2005, Oncogene.

progression and a poorer overall survival identifies a high-risk group of patients with shortened time to disease The presence of TP53 mutation at diagnosis of follicular lymphoma

L. Staudt, A. Rosenwald, W. Chan, 2013 .

Cancer esearch ical Studies E 11 Expression Is Predictive of Cause-Specific Survival wing Radical Radiotherapy for Muscle-Invasive R der Cancer

D. Bishop, R. Bristow, S. Bhattarai, 2010 .

Development of a human acute myeloid leukaemia screening panel and consequent identification of novel gene mutation in FLT3 and CCND3

J. Fitzgibbon, J. Cavenagh, C. Taylor, 2005, British journal of haematology.

Current and emerging techniques for diagnostic mutation detection: an overview of methods for mutation detection.

G. Taylor, C. Taylor, Claire F. Taylor, 2004, Methods in molecular medicine.

Identification of Mutations in Distinct Regions of p85 Alpha in Urothelial Cancer

C. Taylor, M. Knowles, J. Burns, 2013, PloS one.

A comparison of fluorescent SSCP and denaturing HPLC for high throughput mutation scanning

G. Taylor, C. Taylor, L. A. Ellis, 2000, Human mutation.

Expression of hypoxia-inducible factors in human renal cancer: relationship to angiogenesis and to the von Hippel-Lindau gene mutation.

A. Harris, P. Ratcliffe, C. Taylor, 2002, Cancer research.

Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer.

C. Taylor, M. Knowles, P. Selby, 2006, Cancer research.

Does the occurrence of certain rare cancers indicate an inherited cancer susceptibility?

C. Lewis, J. Sanderson, C. Taylor, 2004, Familial Cancer.

Determination of the consequences of VHL mutations on VHL transcripts in renal cell carcinoma

C. Taylor, P. Selby, R. Banks, 2012, International journal of oncology.

Mutation scanning using high-resolution melting.

C. Taylor, Claire F. Taylor, 2009, Biochemical Society transactions.

An integrated genomic, transcriptional and protein investigation of FGFRL1 as a putative 4p16.3 deletion target in bladder cancer

C. Taylor, M. Knowles, J. Roulson, 2013, Genes, chromosomes & cancer.

Prevalence of 9p21 deletions in UK melanoma families

J. Barrett, D. Bishop, C. Taylor, 2005, Genes, chromosomes & cancer.

Frequent inactivating mutations of STAG2 in bladder cancer are associated with low tumour grade and stage and inversely related to chromosomal copy number changes

C. Taylor, M. Knowles, C. Hurst, 2013, Human molecular genetics.

Resistance to the Tubulin-Binding Agents in Renal Cell Carcinoma: No Mutations in the Class I β-Tubulin Gene but Changes in Tubulin Isotype Protein Expression

Rosamonde E Banks, C. Taylor, P. Selby, 2005, Clinical Cancer Research.

Melanoma risk for CDKN2A mutation carriers who are relatives of population-based case carriers in Australia and the UK

J. Barrett, D. Bishop, G. Giles, 2011, Journal of Medical Genetics.

Identification of genetic variants that influence circulating IGF1 levels: a targeted search strategy.

A. Ashworth, J. Peto, O. Fletcher, 2008, Human molecular genetics.

ABT-263 Enhances Sensitivity to Metformin and 2-Deoxyglucose in Pediatric Glioma by Promoting Apoptotic Cell Death

C. Taylor, S. Lawler, L. Steele, 2013, PloS one.

In vitro functional effects of XPC gene rare variants from bladder cancer patients

A. Kiltie, M. Churchman, T. Bishop, 2011, Carcinogenesis.

Papillary and muscle invasive bladder tumors with distinct genomic stability profiles have different DNA repair fidelity and KU DNA‐binding activities

A. Kiltie, C. Taylor, M. Knowles, 2009, Genes, chromosomes & cancer.

FGFR1 Expression and Role in Migration in Low and High Grade Pediatric Gliomas

C. Taylor, Azzam Ismail, S. Short, 2019, Front. Oncol..

Expression of Hypoxia-inducible Factors in Human Renal Cancer : Relationship to Angiogenesis and to the von Hippel-Lindau Gene Mutation 1

A. Harris, P. Ratcliffe, C. Taylor, 2002 .